Synapse - Mark Kris

Search Within

Mark Kris

Results (873)

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors

Journal Article

Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
Clinical Cancer Research (2007)

Fulltext@MSK | Save

Phase I/II study of ABI-007 as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)

Meeting Abstract

Rizvi, N. A.; Azzoli, C.; Miller, V.; Ng, K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M.; Kris, M.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)

Meeting Abstract

Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial

Meeting Abstract

Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Ladanyi, M.; Tsao, A. S.; Sandler, A.; Herbst, R.; Kris, M. G.; Johnson, D. H.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Modern Pathology (2006)

Fulltext@MSK | Save

EGFR mutation analysis in 334 consecutive non-small cell lung cancers: Evidence for frequent amplification of the mutant EGFR allele and survival correlations of mutation type

Meeting Abstract

Li, A. R.; Riely, G. J.; Zakowski, M. F.; Pao, W.; Ma, Y. Y .; Miller, V. A.; Kris, M. G.; Ladanyi, M.
Laboratory Investigation (2006)

Fulltext@MSK | Save

Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy

Meeting Abstract

Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events

Meeting Abstract

Basch, E. M.; McDonough, T.; Iasonos, A.; Siegel, E.; Culkin, A.; Kris, M.; Scher, H. I.; Schrag, D.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Online reporting of toxicity symptoms by lung cancer patients during chemotherapy

Meeting Abstract

Basch, E.; Barz, A.; Kris, M.; Culkin, A.; Schrag, D.
Value in Health (2006)

Fulltext@MSK | Save

Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery, or chemotherapy, in patients with non-small cell lung cancer (NSCLC)

Meeting Abstract

Azzoli, C. G.; Park, S.; Ginex, P.; Vincent, A.; Jones, J.; Venkatraman, E.; Danenberg, K.; Danenberg, P.; Rusch, V. R.; Kris, M. G.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save